Global Continuous Positive Airway Pressure (CPAP) Devices Market, By Product Type (CPAP Masks, CPAP Humidifier, CPAP Motors, Others), By Type (Manual v/s Automatic), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region, Competition Forecast & Opportunities, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 5.24 Billion
CAGR (2026-2031)	7.01%
Fastest Growing Segment	Automatic
Largest Market	North America
Market Size (2031)	USD 7.87 Billion

Market Overview

The Global Continuous Positive Airway Pressure (CPAP) Devices Market will grow from USD 5.24 Billion in 2025 to USD 7.87 Billion by 2031 at a 7.01% CAGR. Continuous Positive Airway Pressure (CPAP) devices are therapeutic respiratory aids designed to maintain open airways in patients with obstructive sleep apnea by delivering a steady stream of pressurized air through a mask. The global market is primarily propelled by the rising prevalence of sleep disorders, an aging demographic, and increasing rates of obesity which collectively intensify the demand for effective respiratory interventions. These fundamental health factors drive market momentum independently of technological trends. According to the American Academy of Sleep Medicine, in 2024, nearly 30 million adults in the United States were estimated to have obstructive sleep apnea, illustrating the substantial addressable patient base necessitating these medical solutions.

Despite this strong demand, market expansion is frequently impeded by the significant challenge of patient non-compliance and device intolerance. Many individuals discontinue therapy due to physical discomfort or claustrophobia which restricts the long-term adoption and replacement of these units. This gap between diagnosis and adherence represents a critical hurdle for revenue growth. According to the National Sleep Foundation, in 2025, approximately 31 percent of adults diagnosed with sleep apnea were not receiving the necessary treatment, signaling a persistent barrier to sustained market penetration and therapeutic success.

Key Market Drivers

Technological innovations in device design and connectivity are fundamentally reshaping the Global Continuous Positive Airway Pressure (CPAP) Devices Market by integrating cloud-based ecosystems that enhance patient adherence and remote monitoring. These smart solutions allow for real-time therapy adjustments and automated data tracking, significantly reducing the high drop-out rates often associated with traditional, non-connected interfaces. This connectivity not only empowers patients to self-monitor but also streamlines clinical workflows for healthcare providers, creating a sticky ecosystem of hardware and software. According to ResMed, October 2024, in the 'Definitive Proxy Statement (DEF 14A)', the company reported a network of 26 million cloud-connectable devices, demonstrating the massive scale of digital adoption in the sector. This technological leverage is a primary engine for commercial performance. According to ResMed, October 2024, in the 'First Quarter 2025 Earnings Press Release', revenue increased by 11 percent, underscoring the strong market demand for these advanced, connected therapeutic solutions.

The rising prevalence of Obstructive Sleep Apnea (OSA) serves as the foundational driver for long-term market expansion, particularly as a vast portion of the global population remains undiagnosed. Increasing awareness campaigns and improved diagnostic accessibility are gradually converting this latent demand into active therapy users, expanding the market beyond established regions. Demographic shifts, including aging populations and rising obesity rates, further exacerbate this public health issue, creating a continuous influx of patients requiring respiratory support. According to ResMed, August 2024, in the '2024 Annual Report', it is estimated that 936 million people globally live with sleep apnea, representing a massive addressable patient pool that far exceeds current treatment penetration. As public health initiatives prioritize sleep hygiene, the gap between the diagnosed population and the total prevalence continues to narrow, fueling sustained device adoption.

Download Free Sample Report

Key Market Challenges

The challenging factor mentioned in the overview that significantly hampers the growth of the Global Continuous Positive Airway Pressure (CPAP) Devices Market is patient non-compliance and device intolerance. This issue presents a substantial barrier to market expansion because the effectiveness of the therapy relies heavily on consistent, long-term usage. When patients experience physical discomfort, mask leaks, or claustrophobia, they often abandon the treatment shortly after diagnosis. This high rate of therapy discontinuation directly negatively impacts the market by reducing the recurring revenue stream generated from the sale of essential consumables such as masks, hoses, and filters, which are a major source of ongoing profit for device manufacturers.

Furthermore, the inability to retain patients on therapy limits the growth of the active user base, thereby stalling the adoption cycle and reducing the demand for replacement devices. This gap between the number of diagnosed patients and those who adhere to the treatment regimen creates a significant inefficiency in the market. According to the American Thoracic Society, in 2024, overall compliance rates for CPAP therapy were reported to be approximately 50 percent. This statistic highlights that nearly half of the potential market for consumables and replacement units is lost due to adherence issues, preventing the industry from realizing its full revenue potential despite the large addressable patient population.

Key Market Trends

The convergence of CPAP therapy with consumer wearables and smart home platforms is acting as a critical catalyst for market expansion by decentralizing diagnostic pathways and funneling undiagnosed patients into treatment pipelines. Tech giants are embedding clinical-grade sleep apnea detection algorithms into popular smartwatches, effectively converting consumer gadgets into preliminary screening tools that bypass complex laboratory procedures. This trend directly addresses the massive undiagnosed patient pool by enabling passive, longitudinal monitoring in a home setting, which triggers medical consultations and subsequent device prescriptions. For instance, according to Samsung Electronics, February 2024, in a press release, the company received De Novo authorization from the U.S. Food and Drug Administration for the sleep apnea feature on its Galaxy Watch, creating a direct consumer channel for identifying moderate to severe obstructive sleep apnea.

Simultaneously, the advancement in minimal-contact mask designs is revolutionizing the patient interface landscape to directly combat high therapy termination rates caused by claustrophobia and physical discomfort. Manufacturers are shifting away from bulky, intrusive headgear toward ultra-lightweight, minimal-contact nasal cradles and pillows that utilize advanced materials and auto-adjusting fit technologies to enhance seal integrity without aggressive pressure. This evolution focuses on "barely-there" aesthetics that significantly improve user tolerance and sustain long-term compliance, ensuring patients replenish consumables regularly. Validating this shift, according to Fisher & Paykel Healthcare, May 2024, in the 'Annual Report 2024', the company reported a 21 percent growth in obstructive sleep apnea mask revenue, specifically attributed to the strong global adoption of their new minimalist mask platforms.

Segmental Insights

The Automatic segment represents the fastest growing category within the Global Continuous Positive Airway Pressure Devices Market. This expansion is attributed to the inherent capability of these devices to vary air pressure breath-by-breath, thereby aligning with specific patient needs during sleep. Consequently, this functionality improves patient compliance and comfort relative to fixed-pressure alternatives. Additionally, the shift towards home-based care has bolstered demand, as these units require less manual intervention. Regulatory clearances from entities such as the US Food and Drug Administration for advanced home-care solutions further validate the safety and efficacy of these automatic systems.

Regional Insights

North America maintains a dominant position in the global Continuous Positive Airway Pressure (CPAP) devices market, primarily driven by the high prevalence of obstructive sleep apnea. This leadership is reinforced by favorable reimbursement policies from institutions such as the Centers for Medicare & Medicaid Services, which significantly improve patient access to care. Additionally, the region benefits from a robust healthcare infrastructure and growing public awareness regarding sleep disorders. The presence of major device manufacturers and structured regulatory pathways defined by the U.S. Food and Drug Administration further support the consistent availability of therapeutic devices to meet demand.

Recent Developments

• In December 2025, SleepRes, Inc. obtained FDA 510(k) clearance for the Kricket PAP device, a new therapeutic solution for obstructive sleep apnea that utilizes Kairos Positive Airway Pressure technology. This proprietary algorithm dynamically adapts pressure delivery by synchronizing with the patient's natural breathing cycle, providing therapeutic pressure primarily during the end-expiration phase when the airway is most susceptible to collapse. By reducing the pressure applied during inspiration and the majority of expiration, the device aims to minimize the discomfort often associated with continuous pressure, potentially improving patient tolerance and adherence to the therapy.
• In September 2024, ResMed launched the AirTouch N30i, a nasal CPAP mask distinguished by its fabric-wrapped frame designed to enhance user comfort. The product incorporates a soft, breathable, and moisture-wicking textile material to provide a more natural look and feel compared to traditional plastic frames. The mask features a tube-up design that allows for greater freedom of movement and utilizes a ComfiSoft cushion, which combines a fabric seal with a silicone coating to ensure effectiveness. This innovation addresses patient feedback regarding comfort and aesthetics, aiming to support long-term adherence to continuous positive airway pressure therapy.
• In April 2024, Fisher & Paykel Healthcare introduced the F&P Solo Nasal mask in the United States market for the treatment of obstructive sleep apnea. This product helps simplify the setup process by utilizing AutoFit technology, which enables users to stretch the mask onto their face and adjust it with a single touch. The mask eliminates conventional straps and clips, employing AutoLock technology to hold the device in place with minimal force while dynamically responding to sleep movements. The system includes a nasal cushion featuring dynamic support technology, designed to keep the cushion comfortably in place while allowing for freedom of movement during sleep.
• In March 2024, ResMed announced the launch of the AirFit F40 in the United States, an ultra-compact full-face mask designed to improve therapy compliance for patients with sleep apnea. The device features a minimalist design with a soft silicone AdaptiSeal cushion intended to maintain a secure facial seal even during movement. It utilizes a fully flexible frame that keeps the mask assembly away from the user's eyes and ears, along with a quick-release short tube to reduce drag. The product aims to deliver the effective pressure support of a traditional full-face mask while offering the comfort and low profile typically associated with smaller mask categories.

Key Market Players

• ResMed Inc.
• Koninklijke Philips N.V.
• Fisher & Paykel Healthcare Limited
• Drive DeVilbiss Healthcare, LLC
• BMC Medical Co., Ltd.
• 3B Medical, Inc.
• Somnetics International, Inc.
• Apex Medical Corporation
• Medtronic plc
• Löwenstein Medical SE & Co. KG

By Product Type	By Type	By End User	By Region
CPAP Masks CPAP Humidifier CPAP Motors Others	Manual v/s Automatic	Hospitals & Clinics Ambulatory Care Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Continuous Positive Airway Pressure (CPAP) Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Continuous Positive Airway Pressure (CPAP) Devices Market, By Product Type:

• CPAP Masks
• CPAP Humidifier
• CPAP Motors
• Others

• Continuous Positive Airway Pressure (CPAP) Devices Market, By Type:

• Manual v/s Automatic

• Continuous Positive Airway Pressure (CPAP) Devices Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

• Continuous Positive Airway Pressure (CPAP) Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE